These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35117784)

  • 1. Oridonin enhances the anti-tumor activity of gemcitabine towards pancreatic cancer by stimulating Bax- and Smac-dependent apoptosis.
    Liu DL; Bu HQ; Wang WL; Luo H; Cheng BN
    Transl Cancer Res; 2020 Jul; 9(7):4148-4161. PubMed ID: 35117784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
    Gui Z; Luo F; Yang Y; Shen C; Li S; Xu J
    Int J Oncol; 2017 Jan; 50(1):111-120. PubMed ID: 27878247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.
    Wang B; Shen C; Li Y; Zhang T; Huang H; Ren J; Hu Z; Xu J; Xu B
    Onco Targets Ther; 2019; 12():5751-5765. PubMed ID: 31410021
    [No Abstract]   [Full Text] [Related]  

  • 4. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells.
    Lou S; Xu J; Wang B; Li S; Ren J; Hu Z; Xu B; Luo F
    Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):814-825. PubMed ID: 31314060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oridonin inhibits BxPC-3 cell growth through cell apoptosis.
    Xu B; Shen W; Liu X; Zhang T; Ren J; Fan Y; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):164-73. PubMed ID: 25651847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
    Bao R; Shu Y; Wu X; Weng H; Ding Q; Cao Y; Li M; Mu J; Wu W; Ding Q; Tan Z; Liu T; Jiang L; Hu Y; Gu J; Liu Y
    BMC Cancer; 2014 Mar; 14():217. PubMed ID: 24655726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells.
    Chen RY; Xu B; Chen SF; Chen SS; Zhang T; Ren J; Xu J
    World J Gastroenterol; 2014 Oct; 20(40):14895-903. PubMed ID: 25356049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
    Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B
    Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin signaling pathway is involved in induction of apoptosis by oridonin in colon cancer COLO205 cells.
    Bu H; Liu D; Cui J; Cai K; Shen F
    Transl Cancer Res; 2019 Sep; 8(5):1782-1794. PubMed ID: 35116929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway.
    Sun KW; Ma YY; Guan TP; Xia YJ; Shao CM; Chen LG; Ren YJ; Yao HB; Yang Q; He XJ
    World J Gastroenterol; 2012 Dec; 18(48):7166-74. PubMed ID: 23326121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc.
    Gao FH; Hu XH; Li W; Liu H; Zhang YJ; Guo ZY; Xu MH; Wang ST; Jiang B; Liu F; Zhao YZ; Fang Y; Chen FY; Wu YL
    BMC Cancer; 2010 Nov; 10():610. PubMed ID: 21054888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line.
    Qi X; Zhang D; Xu X; Feng F; Ren G; Chu Q; Zhang Q; Tian K
    Int J Nanomedicine; 2012; 7():1793-804. PubMed ID: 22619528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-leukemia effect of oridonin on T-cell acute lymphoblastic leukemia].
    Guo Y; Shan QQ; Gong YP; Lin J; Yang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):903-7. PubMed ID: 25571712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
    Jiang JH; Pi J; Jin H; Cai JY
    J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-leukemia effect of oridonin on Ph(+) acute lymphoblastic leukemia cell SUP-B15].
    Guo Y; Shan QQ; Gong YP; Lin J; Yang X; Zhou RQ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):439-43. PubMed ID: 22967375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas.
    Sulaiman MK; Chu Z; Blanco VM; Vallabhapurapu SD; Franco RS; Qi X
    Mol Cancer; 2015 Apr; 14():78. PubMed ID: 25889084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effect of oridonin on colon cancer was mediated by deactivation of TGF-β1/Smads-PAI-1 signaling pathway in vitro and vivo.
    Bu HQ; Shen F; Cui J
    Onco Targets Ther; 2019; 12():7467-7476. PubMed ID: 31686852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study on anti-pancreatic cancer effect of oridonin].
    Wang H; Wang YF; Liu TG; Xiang XL; Huang SL
    Zhong Yao Cai; 2014 Jul; 37(7):1230-3. PubMed ID: 25566662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
    Gu WJ; Liu HL
    Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SmacN7 enhances the sensitivity of pancreatic cancer cells to tumor necrosis factor-related apoptosis-inducing ligand or gemcitabine.
    Zhou W; Shi J; Niu Z; Luo H; Tian H; Gao J; Yu F; Li S
    Oncol Lett; 2013 Jun; 5(6):1760-1764. PubMed ID: 23833637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.